[Stage III NSCLC. The role of the chemotherapist]. / Place du chimiothérapeute.
Rev Mal Respir
; 25(8 Pt 2): 3S95-8, 2008 Oct.
Article
em Fr
| MEDLINE
| ID: mdl-18971832
ABSTRACT
Standard treatment for non resectable stage III non-small cell lung cancer consists of concurrent chemotherapy and thoracic radiotherapy. There is no standard chemotherapy regimen, and several cisplatin-based doublets can be used. Induction and consolidation chemotherapy have been shown to yield no survival benefit. Although maintenance gefitinib has no interest after concurrent chemoradiotherapy, there is a rational for the delivery of targeted therapies in combination with radiotherapy. Other strategies integrating targeted treatments and radiotherapy warrant investigations.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Carcinoma Pulmonar de Células não Pequenas
/
Neoplasias Pulmonares
Limite:
Humans
Idioma:
Fr
Ano de publicação:
2008
Tipo de documento:
Article